853 related articles for article (PubMed ID: 21443475)
1. Lipid-based drug delivery systems for cancer treatment.
Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanomedicines for anticancer drug therapy.
Estella-Hermoso de Mendoza A; Campanero MA; Mollinedo F; Blanco-Prieto MJ
J Biomed Nanotechnol; 2009 Aug; 5(4):323-43. PubMed ID: 20055079
[TBL] [Abstract][Full Text] [Related]
3. Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules.
Holgado MA; Martin-Banderas L; Alvarez-Fuentes J; Fernandez-Arevalo M; Arias JL
Curr Med Chem; 2012; 19(19):3188-95. PubMed ID: 22612702
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Drug targeting strategies in cancer treatment: an overview.
Arias JL
Mini Rev Med Chem; 2011 Jan; 11(1):1-17. PubMed ID: 21235512
[TBL] [Abstract][Full Text] [Related]
6. Liposomes in Active, Passive and Acoustically-Triggered Drug Delivery.
Basha SA; Salkho N; Dalibalta S; Husseini GA
Mini Rev Med Chem; 2019; 19(12):961-969. PubMed ID: 30961495
[TBL] [Abstract][Full Text] [Related]
7. Possibilities of poly(D,L-lactide-co-glycolide) in the formulation of nanomedicines against cancer.
Holgado MA; Alvarez-Fuentes J; Fernández-Arévalo M; Arias JL
Curr Drug Targets; 2011 Jul; 12(8):1096-111. PubMed ID: 21443478
[TBL] [Abstract][Full Text] [Related]
8. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
9. Surface-active liposomes for targeted cancer therapy.
Sofou S
Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
[TBL] [Abstract][Full Text] [Related]
10. Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
Tavano L; Muzzalupo R
Colloids Surf B Biointerfaces; 2016 Nov; 147():161-171. PubMed ID: 27500359
[TBL] [Abstract][Full Text] [Related]
11. Tumor targeting using liposomal antineoplastic drugs.
Huwyler J; Drewe J; Krähenbuhl S
Int J Nanomedicine; 2008; 3(1):21-9. PubMed ID: 18488413
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
Jain V; Jain S; Mahajan SC
Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for Cancer Targeting: Current and Future Directions.
Swain S; Sahu PK; Beg S; Babu SM
Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
[TBL] [Abstract][Full Text] [Related]
14. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
15. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for tumor targeted therapies and their pharmacokinetics.
Wang J; Sui M; Fan W
Curr Drug Metab; 2010 Feb; 11(2):129-41. PubMed ID: 20359289
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnological carriers for cancer chemotherapy: the state of the art.
Estanqueiro M; Amaral MH; Conceição J; Sousa Lobo JM
Colloids Surf B Biointerfaces; 2015 Feb; 126():631-48. PubMed ID: 25591851
[TBL] [Abstract][Full Text] [Related]
18. Smart Drug-Delivery Systems for Cancer Nanotherapy.
Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
[TBL] [Abstract][Full Text] [Related]
19. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]